[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Erlotinib Hydrochloride Market Research Report 2012-2024

July 2019 | 128 pages | ID: G34A469154CEN
HeyReport

US$ 3,470.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body

The global Erlotinib Hydrochloride market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • 25mg
  • 100mg
  • 150mg
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Roche
  • Cipla
  • Mylan
  • Teva
  • OSI Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Beacon Pharmaceuticals
  • Raichem Lifesciences
  • United Biotech
  • CJ Corporation
  • Vivimed Labs
  • Boryung Pharmaceutical
  • Taj Pharmaceuticals
  • Pharmascience
  • Natco Pharma
  • Intas Pharmaceuticals
  • RPG Life Sciences
  • Pharmascience
  • Schwarz Pharma
  • Dr. Reddy’s Laboratories
  • Glenmark Pharmaceuticals
  • Chugai Pharmaceutical
  • DKSH
  • Firma Chun Cheong
  • Kremers Urban Pharmaceuticals
  • Ortat
  • Zuellig Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Non-small Cell Lung Cancer
  • Pancreatic Cancer
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 25mg
    1.2.1.2 100mg
    1.2.1.3 150mg
  1.2.2 by Application
    1.2.2.1 Non-small Cell Lung Cancer
    1.2.2.2 Pancreatic Cancer
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 25mg Market, 2013-2018
  4.1.2 100mg Market, 2013-2018
  4.1.3 150mg Market, 2013-2018
4.2 Market Forecast
  4.2.1 25mg Market Forecast, 2019-2024
  4.2.2 100mg Market Forecast, 2019-2024
  4.2.3 150mg Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Non-small Cell Lung Cancer Market, 2013-2018
  5.1.2 Pancreatic Cancer Market, 2013-2018
5.2 Market Forecast
  5.2.1 Non-small Cell Lung Cancer Market Forecast, 2019-2024
  5.2.2 Pancreatic Cancer Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Roche
8.2 Cipla
8.3 Mylan
8.4 Teva
8.5 OSI Pharmaceuticals
8.6 Glenmark Pharmaceuticals
8.7 Beacon Pharmaceuticals
8.8 Raichem Lifesciences
8.9 United Biotech
8.10 CJ Corporation
8.11 Vivimed Labs
8.12 Boryung Pharmaceutical
8.13 Taj Pharmaceuticals
8.14 Pharmascience
8.15 Natco Pharma
8.16 Intas Pharmaceuticals
8.17 RPG Life Sciences
8.18 Pharmascience
8.19 Schwarz Pharma
8.20 Dr. Reddy’s Laboratories
8.21 Glenmark Pharmaceuticals
8.22 Chugai Pharmaceutical
8.23 DKSH
8.24 Firma Chun Cheong
8.25 Kremers Urban Pharmaceuticals
8.26 Ortat
8.27 Zuellig Pharma

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Erlotinib Hydrochloride
Table Products Segment of Erlotinib Hydrochloride
Table 25mg Overview
Table 100mg Overview
Table 150mg Overview
Table Global Erlotinib Hydrochloride Market by Type, 2011-2022 (USD Million)
Table Application Segment of Erlotinib Hydrochloride
Table Non-small Cell Lung Cancer Overview
Table Pancreatic Cancer Overview
Table Global Erlotinib Hydrochloride Market by Application, 2011-2022 (USD Million)
Table Global Erlotinib Hydrochloride Market by Region, 2011-2022 (USD Million)
Table Cost of Erlotinib Hydrochloride
Table Market Dynamics
Table Policy of Erlotinib Hydrochloride
Table GDP of Major Countries
Table 25mg CAGR by Revenue and Volume, 2012-2018
Table 100mg CAGR by Revenue and Volume, 2012-2018
Table 150mg CAGR by Revenue and Volume, 2012-2018
Table 25mg CAGR by Revenue and Volume, 2012-2024
Table 100mg CAGR by Revenue and Volume, 2012-2024
Table 150mg CAGR by Revenue and Volume, 2012-2024
Table Non-small Cell Lung Cancer CAGR by Revenue and Volume, 2012-2018
Table Pancreatic Cancer CAGR by Revenue and Volume, 2012-2018
Table Global Erlotinib Hydrochloride Market by Vendors, 2012-2018 (USD Million)
Table Global Erlotinib Hydrochloride Market by Vendors, 2012-2018 (in Volume)
Table Global Erlotinib Hydrochloride Market Share by Vendors, 2012-2018 (USD Million)
Table Global Erlotinib Hydrochloride Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Profile List
Table Microecological Modulator Operating Data of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OSI Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of OSI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glenmark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Beacon Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Beacon Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Raichem Lifesciences Profile List
Table Microecological Modulator Operating Data of Raichem Lifesciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table United Biotech Profile List
Table Microecological Modulator Operating Data of United Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CJ Corporation Profile List
Table Microecological Modulator Operating Data of CJ Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vivimed Labs Profile List
Table Microecological Modulator Operating Data of Vivimed Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boryung Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Boryung Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Taj Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Taj Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmascience Profile List
Table Microecological Modulator Operating Data of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Natco Pharma Profile List
Table Microecological Modulator Operating Data of Natco Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Intas Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table RPG Life Sciences Profile List
Table Microecological Modulator Operating Data of RPG Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmascience Profile List
Table Microecological Modulator Operating Data of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Schwarz Pharma Profile List
Table Microecological Modulator Operating Data of Schwarz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy’s Laboratories Profile List
Table Microecological Modulator Operating Data of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glenmark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Chugai Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Chugai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table DKSH Profile List
Table Microecological Modulator Operating Data of DKSH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Firma Chun Cheong Profile List
Table Microecological Modulator Operating Data of Firma Chun Cheong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kremers Urban Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Kremers Urban Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ortat Profile List
Table Microecological Modulator Operating Data of Ortat (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zuellig Pharma Profile List
Table Microecological Modulator Operating Data of Zuellig Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

LIST OF FIGURES

Figure Erlotinib Hydrochloride Picture
Figure Industry Chain Structure of Erlotinib Hydrochloride
Figure SWOT of Erlotinib Hydrochloride
Figure 25mg Market Size and Growth, 2012-2018 (USD Million)
Figure 25mg Market Size and Growth, 2012-2018 (in Volume)
Figure 100mg Market Size and Growth, 2012-2018 (USD Million)
Figure 100mg Market Size and Growth, 2012-2018 (in Volume)
Figure 150mg Market Size and Growth, 2012-2018 (USD Million)
Figure 150mg Market Size and Growth, 2012-2018 (in Volume)
Figure 25mg Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure 25mg Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure 100mg Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure 100mg Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure 150mg Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure 150mg Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Non-small Cell Lung Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Pancreatic Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Erlotinib Hydrochloride Market Concentration by Region
Figure Marketing Channels Overview


More Publications